Skip to main content

News

desc
24 October 2019

Prof. Mats Ohlin from the Dept. of Immunotechnology today received a grant of 2.4 MSEK from the Swedish Research Council to fund research on human antibodies in allergic disease.

desc
22 October 2019

A recent study of antibody recognition of a major mite allergen, an allergy-causing substance, was featured on the Nov 1, 2019 issue of the Journal of Immunology. In this study researchers from the Dept. of Immunotechnology, in collaboration with reasearchers from Indoor Biotechnologies, Inc., the University of South Carolina, the National [...]

desc
28 May 2019

Jakob Willforss of the Department of Immunotechnology was, following a public vote, awarded a poster prize at 'Proteomic Forum 2019' which recently took place in Potsdam, Germany. He presented a poster entitled 'Evaluation of peptide quantification susceptibility for technical bias from batch effects and batch compensation'. In this study he [...]

desc
21 May 2019

Mechanistic Toxicology

desc
20 May 2019

Milad Abolhalaj, doctoral researcher at the Dept. of Immunotechnology, exhibits pieces of art at LTH's Art Exhibition that opens May 20th, 2019.

desc
24 April 2019

Dr. Mattias Brofelth of the Dept. of Immunotechnology was awarded the Stiftelsen Oscar II:s stipend for his doctoral thesis entitled Technological advancements in affinity proteomics: From planar antibody microarrays towards a solution-based platform.

desc
8 March 2019

Researchers from 12 countries in Europe, America, Africa, Asia and Oceania incl. researchers from the Department of Immunotechnology have published a system for validation and naming of newly discovered genes that the immune system uses to create the antibodies that protect us, for example against infections. The work has been carried out within [...]

desc
10 December 2018

Department of Immunotechnology researchers are hosting this years lecture on the 14th of Dec

desc
10 December 2018

Alligator Biosciences, ett av Institutionens avknoppningsbolag är idag med i Sydsvenskan. Bolagets viktigaste produkt är antikroppar riktade mot cancerceller, en vidareutveckling av den upptäckt som i år tilldelades årets Nobelpris i medicine.  Läs mer här.

desc
10 December 2018

Institutionen för Immunteknologi grundare Professor Carl Borrebaeck och en av årets nobelprisvinnare i kemi, sir Gregory Winter, arbetade tidigare sida vid sida med att publicera en ny teknologi inom ett då nytt och hett område kallat ”antibody engineering”. 1989 publicerade båda forskarna inom ett par veckor rön om den teknologi som nu ligger till [...]

Page Manager: jana.hagman@immun.lth.se | 2022-11-21